BACKGROUND: Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous subtypes. Previously, study size has limited the ability to compare and contrast the risk factor profiles among these heterogeneous subtypes. METHODS: We pooled individual-level data from 17 471 NHL cases and 23 096 controls in 20 case-control studies from the International Lymphoma Epidemiology Consortium (InterLymph). We estimated the associations, measured as odds ratios, between each of 11 NHL subtypes and self-reported medical history, family history of hematologic malignancy, lifestyle factors, and occupation. We then assessed the heterogeneity of associations by evaluating the variability (Q value) of the estimated odds ratios for a given exposure among subtypes. Finally, we organized the subtypes into a hierarchical tree to identify groups that had similar risk factor profiles. Statistical significance of tree partitions was estimated by permutation-based P values (P NODE). RESULTS: Risks differed statistically significantly among NHL subtypes for medical history factors (autoimmune diseases, hepatitis C virus seropositivity, eczema, and blood transfusion), family history of leukemia and multiple myeloma, alcohol consumption, cigarette smoking, and certain occupations, whereas generally homogeneous risks among subtypes were observed for family history of NHL, recreational sun exposure, hay fever, allergy, and socioeconomic status. Overall, the greatest difference in risk factors occurred between T-cell and B-cell lymphomas (P NODE < 1.0×10(-4)), with increased risks generally restricted to T-cell lymphomas for eczema, T-cell-activating autoimmune diseases, family history of multiple myeloma, and occupation as a painter. We further observed substantial heterogeneity among B-cell lymphomas (P NODE < 1.0×10(-4)). Increased risks for B-cell-activating autoimmune disease and hepatitis C virus seropositivity and decreased risks for alcohol consumption and occupation as a teacher generally were restricted to marginal zone lymphoma, Burkitt/Burkitt-like lymphoma/leukemia, diffuse large B-cell lymphoma, and/or lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. CONCLUSIONS: Using a novel approach to investigate etiologic heterogeneity among NHL subtypes, we identified risk factors that were common among subtypes as well as risk factors that appeared to be distinct among individual or a few subtypes, suggesting both subtype-specific and shared underlying mechanisms. Further research is needed to test putative mechanisms, investigate other risk factors (eg, other infections, environmental exposures, and diet), and evaluate potential joint effects with genetic susceptibility. Published by Oxford University Press 2014.
BACKGROUND: Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous subtypes. Previously, study size has limited the ability to compare and contrast the risk factor profiles among these heterogeneous subtypes. METHODS: We pooled individual-level data from 17 471 NHL cases and 23 096 controls in 20 case-control studies from the International Lymphoma Epidemiology Consortium (InterLymph). We estimated the associations, measured as odds ratios, between each of 11 NHL subtypes and self-reported medical history, family history of hematologic malignancy, lifestyle factors, and occupation. We then assessed the heterogeneity of associations by evaluating the variability (Q value) of the estimated odds ratios for a given exposure among subtypes. Finally, we organized the subtypes into a hierarchical tree to identify groups that had similar risk factor profiles. Statistical significance of tree partitions was estimated by permutation-based P values (P NODE). RESULTS: Risks differed statistically significantly among NHL subtypes for medical history factors (autoimmune diseases, hepatitis C virus seropositivity, eczema, and blood transfusion), family history of leukemia and multiple myeloma, alcohol consumption, cigarette smoking, and certain occupations, whereas generally homogeneous risks among subtypes were observed for family history of NHL, recreational sun exposure, hay fever, allergy, and socioeconomic status. Overall, the greatest difference in risk factors occurred between T-cell and B-cell lymphomas (P NODE < 1.0×10(-4)), with increased risks generally restricted to T-cell lymphomas for eczema, T-cell-activating autoimmune diseases, family history of multiple myeloma, and occupation as a painter. We further observed substantial heterogeneity among B-cell lymphomas (P NODE < 1.0×10(-4)). Increased risks for B-cell-activating autoimmune disease and hepatitis C virus seropositivity and decreased risks for alcohol consumption and occupation as a teacher generally were restricted to marginal zone lymphoma, Burkitt/Burkitt-like lymphoma/leukemia, diffuse large B-cell lymphoma, and/or lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. CONCLUSIONS: Using a novel approach to investigate etiologic heterogeneity among NHL subtypes, we identified risk factors that were common among subtypes as well as risk factors that appeared to be distinct among individual or a few subtypes, suggesting both subtype-specific and shared underlying mechanisms. Further research is needed to test putative mechanisms, investigate other risk factors (eg, other infections, environmental exposures, and diet), and evaluate potential joint effects with genetic susceptibility. Published by Oxford University Press 2014.
Authors: Ellen T Chang; Karin Ekström Smedby; Henrik Hjalgrim; Bengt Glimelius; Hans-Olov Adami Journal: J Natl Cancer Inst Date: 2006-01-04 Impact factor: 13.506
Authors: N Porakishvili; R Mageed; C Jamin; J O Pers; N Kulikova; Y Renaudineau; P M Lydyard; P Youinou Journal: Scand J Immunol Date: 2001 Jul-Aug Impact factor: 3.487
Authors: Christine F Skibola; Susan L Slager; Sonja I Berndt; Tracy Lightfoot; Joshua N Sampson; Lindsay M Morton; Dennis D Weisenburger Journal: J Natl Cancer Inst Monogr Date: 2014-08
Authors: Sietse M Aukema; Reiner Siebert; Ed Schuuring; Gustaaf W van Imhoff; Hanneke C Kluin-Nelemans; Evert-Jan Boerma; Philip M Kluin Journal: Blood Date: 2010-11-30 Impact factor: 22.113
Authors: E V Kane; E Roman; N Becker; L Bernstein; P Boffetta; P M Bracci; J R Cerhan; B C-H Chiu; P Cocco; L Costas; L Foretova; E A Holly; C La Vecchia; K Matsuo; M Maynadie; S Sanjose; J J Spinelli; A Staines; R Talamini; S S Wang; Y Zhang; T Zheng; A Kricker Journal: Ann Oncol Date: 2012-07-10 Impact factor: 32.976
Authors: Eleanor V Willett; Lindsay M Morton; Patricia Hartge; Nikolaus Becker; Leslie Bernstein; Paolo Boffetta; Paige Bracci; James Cerhan; Brian C-H Chiu; Pierluigi Cocco; Luigino Dal Maso; Scott Davis; Silvia De Sanjose; Karin Ekstrom Smedby; Maria Grazia Ennas; Lenka Foretova; Elizabeth A Holly; Carlo La Vecchia; Keitaro Matsuo; Marc Maynadie; Mads Melbye; Eva Negri; Alexandra Nieters; Richard Severson; Susan L Slager; John J Spinelli; Anthony Staines; Renato Talamini; Martine Vornanen; Dennis D Weisenburger; Eve Roman Journal: Int J Cancer Date: 2008-05-01 Impact factor: 7.396
Authors: Yawei Zhang; Silvia De Sanjose; Paige M Bracci; Lindsay M Morton; Rong Wang; Paul Brennan; Patricia Hartge; Paolo Boffetta; Nikolaus Becker; Marc Maynadie; Lenka Foretova; Pierluigi Cocco; Anthony Staines; Theodore Holford; Elizabeth A Holly; Alexandra Nieters; Yolanda Benavente; Leslie Bernstein; Shelia Hoar Zahm; Tongzhang Zheng Journal: Am J Epidemiol Date: 2008-04-11 Impact factor: 4.897
Authors: C A Clarke; L M Morton; C Lynch; R M Pfeiffer; E C Hall; T M Gibson; D D Weisenburger; O Martínez-Maza; S K Hussain; J Yang; E T Chang; E A Engels Journal: Br J Cancer Date: 2013-06-11 Impact factor: 9.075
Authors: Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-15 Impact factor: 4.254
Authors: Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns Journal: Biol Blood Marrow Transplant Date: 2016-09-12 Impact factor: 5.742
Authors: Megan M Herr; Sara J Schonfeld; Graça M Dores; Diana R Withrow; Margaret A Tucker; Rochelle E Curtis; Lindsay M Morton Journal: J Natl Cancer Inst Date: 2018-11-01 Impact factor: 13.506
Authors: Yu-Han Chiu; Kimberly A Bertrand; Shumin Zhang; Francine Laden; Mara M Epstein; Bernard A Rosner; Stephanie Chiuve; Hannia Campos; Edward L Giovannucci; Jorge E Chavarro; Brenda M Birmann Journal: Int J Cancer Date: 2018-08-10 Impact factor: 7.396
Authors: Laura Costas; Leila Lujan-Barroso; Yolanda Benavente; Naomi E Allen; Pilar Amiano; Eva Ardanaz; Caroline Besson; Heiner Boeing; Bas Bueno-de-Mesquita; Iris Cervenka; Renée T Fortner; Agnès Fournier; Marc Gunter; Sophia Harlid; José María Huerta; Mats Jerkeman; Karin Jirström; Rudolf Kaaks; Anna Karakatsani; Kay-Tee Khaw; Anastasia Kotanidou; Eiliv Lund; Giovanna Masala; Amalia Mattiello; Beatrice Melin; Virginia Menéndez; Neil Murphy; Alexandra Nieters; Kim Overvad; Elio Riboli; Carlotta Sacerdote; Maria-Jose Sánchez; Julie A Schmidt; Sabina Sieri; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Roel Vermeulen; Elisabete Weiderpass; Silvia de Sanjosé; Antonio Agudo; Delphine Casabonne Journal: Am J Epidemiol Date: 2019-02-01 Impact factor: 4.897
Authors: Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04-26 Impact factor: 4.254
Authors: Curt T DellaValle; Nicole C Deziel; Rena R Jones; Joanne S Colt; Anneclaire J De Roos; James R Cerhan; Wendy Cozen; Richard K Severson; Abigail R Flory; Lindsay M Morton; Mary H Ward Journal: Cancer Causes Control Date: 2015-11-16 Impact factor: 2.506